Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Graphite Bio Inc (NQ: GRPH ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Graphite Bio Inc < Previous 1 2 Next > Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics March 08, 2024 From Graphite Bio, Inc. Via Business Wire GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH February 27, 2024 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. December 11, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR) December 04, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR) December 04, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR), November 27, 2023 From Brodsky & Smith LLC Via GlobeNewswire GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH November 17, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WaveDancer, Inc. (Nasdaq – WAVD), Selecta Biosciences, Inc. (Nasdaq – SELB), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR) November 16, 2023 From Brodsky & Smith LLC Via GlobeNewswire GRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to Shareholders November 15, 2023 From Halper Sadeh LLC Via Business Wire LENZ Therapeutics and Graphite Bio Announce Merger Agreement November 15, 2023 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Departure of Chief Financial Officer June 23, 2023 From Graphite Bio, Inc. Via Business Wire Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial Results March 20, 2023 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring February 22, 2023 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease January 05, 2023 From Graphite Bio, Inc. Via Business Wire Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting December 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference November 21, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results November 09, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition November 03, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention October 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Morgan Stanley 20th Annual Global Healthcare Conference September 06, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Reports Recent Business Progress and Second Quarter 2022 Financial Results August 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell Disease August 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Jefferies Healthcare Conference June 01, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio, Inc. (NASDAQ:GRPH) Investor Alert: Investigation over Potential Wrongdoing May 26, 2022 San Diego, CA -- (SBWIRE) -- 05/26/2022 -- An investigation on behalf of current long-term investors in shares of Graphite Bio, Inc. (NASDAQ:GRPH) was announced over potential breaches of fiduciary... Via SBWire Graphite Bio Presents Preclinical Gene Replacement Data for GPH102 for Beta-thalassemia at the ASGCT 25th Annual Meeting May 16, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Reports Recent Business Progress and First Quarter 2022 Financial Results May 12, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Upcoming Investor Conferences May 04, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell Disease May 03, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in the ASGCT 25th Annual Meeting Including Oral Presentation About Beta-thalassemia Program May 02, 2022 From Graphite Bio, Inc. Via Business Wire NASDAQ:GRPH Shareholder Notice: Investigation over Possible Securities Laws Violations by Graphite Bio, Inc. April 13, 2022 San Diego, CA -- (SBWIRE) -- 04/13/2022 -- Graphite Bio, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.